Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-08-07

Clinical Trial Update: Androgen Deprivation Therapy in Treating Patients With Prostate Cancer [Phase 3]

View source ↗

Summary

Clinical trial update on a Phase 3 study evaluating androgen deprivation therapy for prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Androgen deprivation therapy (Androgen deprivation therapy)

Snippet

Sponsor: Peter MacCallum Cancer Centre, Australia | Conditions: Prostate Cancer | Phase 3 | Status: UNKNOWN